SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,506.65 |
| Enterprise Value ($M) | 3,996.87 |
| Book Value ($M) | 588.00 |
| Book Value / Share | 3.70 |
| Price / Book | 7.66 |
| NCAV ($M) | 205.00 |
| NCAV / Share | 1.29 |
| Price / NCAV | 21.98 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.18 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -1.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.47 |
| Current Ratio | 8.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,620.00 |
| Assets | 3,003.00 |
| Liabilities | 2,415.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 705.00 |
| Operating Income | -475.00 |
| Net Income | -454.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -500.95 |
| Cash from Investing | -134.03 |
| Cash from Financing | 478.06 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 5.70 | 0.10 | |
| 13G | Capital World Investors | 7.30 | ||
| 13G/A | T. Rowe Price Investment Management, Inc. | 10.00 | 11.88 | |
| 13G/A | Vanguard Group Inc | 10.43 | 15.98 | |
| 13G/A | Bb Biotech Ag | 5.00 | -8.61 | |
| 13G | Wellington Management Group Llp | 5.76 | 34.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 166,956 | 693,959 | 24.06 | |
| 501,279 | 1,397,712 | 35.86 | |
| 312,714 | 904,122 | 34.59 | |
| 835,449 | 2,155,594 | 38.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INVA – Innoviva, Inc. | INZY – Inozyme Pharma, Inc. |
| IOBT – IO Biotech, Inc. | IPSC – Century Therapeutics, Inc. |
| IRWD – Ironwood Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io